This study also demonstrated that AT1R selective antagonist (L-158,809) suppresses the growth of human pancreatic cancer which suggests the role of Ang II and AT1R in pancreatic cancer [277]. This evidence concerns the gene AGTR1 and pancreatic neoplasm.